Eswatini vs Guinea-Bissau: Population requiring preventive chemotherapy for schistosomiasis
Eswatini
411,702
in 2024
Guinea-Bissau
399,321
in 2024
Eswatini rank
40th
Guinea-Bissau rank
41st
Population requiring preventive chemotherapy for schistosomiasis over time
- Eswatini
- Guinea-Bissau
How they compare
Eswatini currently reports 411,702 against 399,321 in Guinea-Bissau, a difference of 12,381.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Eswatini ahead.
Eswatini ranks 40th and Guinea-Bissau ranks 41st of 52 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 304,182 | 219,316 | 84,865 | Eswatini |
| 2020s | 340,355 | 221,684 | 118,670 | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Eswatini or Guinea-Bissau?
- Eswatini, at 411,702 against 399,321 in Guinea-Bissau as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Eswatini and Guinea-Bissau?
- 12,381, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Guinea-Bissau?
- 15 years are reported by both, from 2010 to 2024.
- How do Eswatini and Guinea-Bissau rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Eswatini ranks 40th and Guinea-Bissau ranks 41st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.